Studying Patterns in Patient Engagement Among Treatment Resistant Depression Patients

Starting soon

Conditions studied: Treatment Resistant Depression

In brief

Clinical studies, with a distinct focus on treatment resistant depression, play a crucial role in evaluating the safety and effectiveness of novel treatments. These trials serve as instrumental means to determine whether new medications surpass conventional therapies, providing substantial evidence for their broader adoption. The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this specific patient group.

Key facts

Study ID

NCT06101914

Run by

Power Life Sciences Inc.

People needed

500

Starts

2024-11-01

Expected to finish

2026-11-01

Last updated by the study team

2023-10-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of treatment resistant depression
• Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
• No prior treatment for treatment resistant depression

You may not qualify if…

• Enrolled in another research study
• Inability to provide written informed consent
• Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial

Where it is running

• Power Life Sciences — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.